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2Why do we think adherence so low?
 “What we need are new ways to improve human motivation 
to take the medications… The holy grail here is to add 
motivation innovation to the mix”
 Firlik, K., 2013. Why I went from neurosurgeon to entrepreneur
 But what about:
– Poor instructions, disrupted patient routines, bad size/taste, side-
effects, lack of support, complex regimens, lack of storage, lack of 
access, stigma….
 “At the centre of service delivery is the patient”
 Musgrove, P., et al., 2000. Health systems: improving performance
– Do we actually know what patients want and understand their 
consumption contexts?
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Adherence definitions through the years
Year Definition Reference
2007 “the extent to which patients follow the instructions they are given 
for prescribed treatments”
Munro, Lewin, Swart, 
& Volmink
2009 “the extent to which the patient’s behaviour matches agreed 
recommendations from the prescriber”
Nunes et al.
2011 “initiating the prescription, actual dosing in relation to the 
prescription, and persisting with treatment”
Eliasson, Barber, & 
Weinman
2012 “the extent of conformity to treatment recommendations with 
respect to the timing, dosage, frequency, and duration of a 
prescribed medication”
Gadkari & McHorney
2013 “the process by which patients take their medications as prescribed. 
Adherence has three components: initiation, implementation, and 
discontinuation”
Kardas, Lewek, & 
Matyjaszczyk
2014 “correctly taking the full therapeutic course of treatment” Bruxvoort, Goodman, 
Kachur, & 
Schellenberg
2014 “those who reported to have taken the treatment as recommended 
(in terms of timing and dosage) with no tablets remaining”
Banek, Lalani, 
Staedke, & 
Chandramohan
2015 “a ratio of the number of drug doses taken to the number of doses 
prescribed over a given time period”
Morrison, Stauffer, & 
Kaufman
Year Definition Reference
2002 “the extent to which a patient’s behavior (in terms of taking 
medication, following a diet, modifying habits, or attending clinics) 
coincides with medical or health advice”
McDonald, Garg, & 
Haynes
2007 “% of Prescribed pills taken… >80% of prescribed pills taken… [non-
adherence is] failing to collect medications for 2 consecutive months”
Kripalani, Yao, & 
Haynes
2015 “[non-adherence is] lack of correct behavior” Tsega, Srikanth, & 
Shewamene
2015 “the extent to which patients follow the instructions given for 
prescribed medications”
Chew, Hassan, & 
Sherina
2015 “both compliance (proximity to treatment recommendation often 
simplified as the number of doses taken divided by the number of 
prescribed doses) and persistence (how long the medication is 
taken)”
Touskova et al.
2015 “self-reporting to have correctly taken the entire course of 
treatment”
Gore-Langton et al.
2015 “the extent to which [patients] have altered their dose, forgotten to 
use the medication, stopped taking it for a while, decided to miss out 
on a dose, and taken less than instructed… adherence being defined 
as answering “never” to all five”
Sandy & Connor
Practice papers
Theoretical papers
4Do we know what adherence looks like?
Morrison, A., Stauffer, M.E., Kaufman, A.S., 2015. Defining medication adherence in individual patients.
Patient Preference and Adherence 9, p.893–897.
5Who is responsible for patient adherence?
 Pharmaceutical manufacturers?
– “I really believe that in the future, companies like Novartis are going to be 
paid on patient outcomes as opposed to selling the pill”
 Joseph Jimenez, Novartis CEO, 2014
 Practitioners?
– “…pharmacists have the potential to perform a central role in providing 
consumers with the relevant information they need to make responsible 
decisions that lead to increased adherence”
 Kreps, G.L., et al., 2011. Development and validation of motivational messages to 
improve prescription medication adherence for patients with chronic health 
problems. Patient Educ. Couns. 83, p.375–81.
 Patients?
– “…the patient is free to decide whether to take the treatment or not”
 Nunes, V., et al., 2009. Clinical Guidelines and Evidence Review for Medicines 
Adherence: involving patients in decisions about prescribed medicines and 
supporting adherence. Royal College of General Practitioners, London, UK.
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6Let us define adherence around the patient
 Adherence is using skills and resources to follow an 
externally imposed pattern of behaviour sufficiently to 
achieve the patient’s objectives in context
 Implications include:
– Pharmaceutical manufacturers must ensure drug formulations 
take full account of patient objectives and contexts
– Patient information from all sources must be comprehensible and 
consistent
– Practitioners must acknowledge where the power lies and 
educate patients through dialogue
– The focus then shifts from arcane calculations to guiding patients 
on how best to achieve their objectives
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Thank you!
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